Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis
Eleni Efstathiou
Fil Manuguid
Peter Kirkpatrick

Showing results (81-90 of 476) with videos related to

Pageof 48
Sort By:
The Lancet. Oncology|September 14, 2019
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trialPaul G Corn, Elisabeth I Heath, Amado Zurita, et al.
Oncotarget|June 23, 2016
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Styliani Karanika, Jianxiang Wang, et al.
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Multimodality therapy: bone-targeted radioisotope therapy of prostate cancerShi-Ming Tu, Sue-Hwa Lin, Donald A Podoloff, et al.
Histopathology|June 29, 2011
Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signallingVassiliki Tzelepi, Maria Karlou, Sijin Wen, et al.
The Prostate|May 22, 2014
Androgenic biomarker prof|ling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometryJohn H Wilton, Mark A Titus, Eleni Efstathiou, et al.
Frontiers in Oncology|September 5, 2025
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancerHimisha Beltran, Jeremie Calais, Louise Emmett, et al.
Nature Reviews. Drug Discovery|March 11, 2005
NatalizumabJohn H Noseworthy, Peter Kirkpatrick
Nature Reviews. Drug Discovery|November 24, 2004
Duloxetine hydrochlorideAnathea B Waitekus, Peter Kirkpatrick
Nature Reviews. Drug Discovery|June 18, 2005
PregabalinRobert H Dworkin, Peter Kirkpatrick
Computational and Mathematical Methods in Medicine|December 25, 2013
Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progressionHongya Zhao, Christopher J Logothetis, Ivan P Gorlov, et al.
Pageof 48

Showing results (81-90 of 476) with videos related to

Sort By:
Pageof 48
The Lancet. Oncology|September 14, 2019
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trialPaul G Corn, Elisabeth I Heath, Amado Zurita, et al.
Oncotarget|June 23, 2016
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Styliani Karanika, Jianxiang Wang, et al.
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Multimodality therapy: bone-targeted radioisotope therapy of prostate cancerShi-Ming Tu, Sue-Hwa Lin, Donald A Podoloff, et al.
Histopathology|June 29, 2011
Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signallingVassiliki Tzelepi, Maria Karlou, Sijin Wen, et al.
The Prostate|May 22, 2014
Androgenic biomarker prof|ling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometryJohn H Wilton, Mark A Titus, Eleni Efstathiou, et al.
Frontiers in Oncology|September 5, 2025
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancerHimisha Beltran, Jeremie Calais, Louise Emmett, et al.
Nature Reviews. Drug Discovery|March 11, 2005
NatalizumabJohn H Noseworthy, Peter Kirkpatrick
Nature Reviews. Drug Discovery|November 24, 2004
Duloxetine hydrochlorideAnathea B Waitekus, Peter Kirkpatrick
Nature Reviews. Drug Discovery|June 18, 2005
PregabalinRobert H Dworkin, Peter Kirkpatrick
Computational and Mathematical Methods in Medicine|December 25, 2013
Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progressionHongya Zhao, Christopher J Logothetis, Ivan P Gorlov, et al.
Pageof 48